Pfizer / BioNTech vaccine - fb

The Chief Executive of German pharmaceutical company BioNTech says the company is confident its COVID-19 vaccine works against the new UK variant, adding, however, that further studies are needed to be completely sure.

Detected mainly in London and the southeast of England, the new COVID-19 variant has been a cause for concern across the globe because of indications that it may spread more easily.

While so far there has been no indication that the new variant causes increased mortality, several countries in Europe have restricted travel from the UK as a result, Malta included.

The BioNTech chief, Ugar Sahin, said at a press conference that “the likelihood that our vaccine works…is relatively high”.

On Wednesday, the day after the EU approved use of the Pfizer/BioNTech vaccine, BioNTech CEO Ugur Sahin told a news conference:

“We don’t know at the moment if our vaccine is also able to provide protection against this new variant….But, scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variants.”

Mr Sahin said the proteins on the UK variant are 99 per cent the same as the prevailing strains, and therefore BioNTech has “scientific confidence” that its vaccine will be effective.

He added that the company will know only if the experiment is done, which will need about two weeks from not to get the data.

Malta will start to roll out Pfizer/BioNTech COVID-19 vaccines from this Sunday, after the EU approved its use.

‘A unique opportunity to connect with highly-successful brands’ – Joseph Gerada, FBO Regulator

July 24, 2024
by Ramona Depares

This year’s EFB Summit offers local family businesses the opportunity to be part of Malta’s delegation in Rome, he explains

Major luxury brands experience slump as wealthy shoppers in China hold back

July 24, 2024
by Helena Grech

LVMH, Richemont, Hugo Boss and Swatch Group have all reported lower sales in the region

Google parent company Alphabet set to buy cybersecurity startup Wiz, its biggest acquisition yet

July 16, 2024
by Anthea Cachia

Acquisiton figures are double the valuation of the company